ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in April 2024. Updated April 25, 2024.
A roundup of FDA’s actions in April 2024
FDA Output April 2024
×
